地舒单抗售价是多少呢？

The so-called bone transfer acupuncture is a drug that can clinically treat or prevent bone metastasis. The drug that is used more clinically in China is called "zoledronic acid", but one of the biggest side effects of this acupuncture is that it may cause femoral head necrosis. The reputation among the patient group is not very good, so what is currently recommended is a more suitable bone-turning drug. The trade name of denosumab is XGEVA. It was originally used to treat osteoporosis in menopausal women. It was developed by AMGEN and was approved by the FDA in 2010.

So, how much does denosumab cost?

Domestic price of denosumab: In May 2019, the domestic market of denosumab was conditionally approved. However, because it was conditionally approved and it was only on the market for five months, the domestic selling price of this drug cannot be collected.

The price of denosumab abroad: the price of denosumab 120mg produced by Amgen in the United States is about 3,000$. Due to the floating exchange rate, the price will be different. Please consult the medical companion for the specific price!

In addition, bone metastasis often occurs in the lumbar spine, thoracic spine, femur and other parts. Once bone metastasis occurs in these parts, if it cannot be treated in time or is handled improperly, it will lead to complications, loss of mobility or death.

The use of denosumab is very critical: injection dose: 120mg/time; injection cycle: 4 weeks/time; injection method: subcutaneous injection; injection duration: at least 6 months;

Treatment precautions: If necessary, please supplement calcium and vitamin D to prevent hypocalcemia;

Global clinical data, clinical results show that compared with zoledronic acid, denosumab effectively delays the incidence of first bone metastasis; lung cancer and other solid tumors: denosumab compared with zoledronic acid 20.5 months vs 16.3 months; prostate cancer: denosumab compared with zoledronic acid 20.7 months vs 17.1 months;